Media Center

AAV5 DetectCDx™ Kit Is First ARUP Test Developed to Support a New Therapy

The European Commission’s approval of BioMarin’s novel gene therapy for severe hemophilia A has paved the way for ARUP’s AAV5 DetectCDx™ Kit to become the first ARUP-developed test used in Europe.

NanoSpot.ai Announces Partnership With Opto to Commercialize SARS-CoV-2 Antibody Test in Europe

NanoSpot.ai’s European commercialization agreement is the first for an antibody test originally developed through an ARUP/University of Utah/Techcyte partnership.

ARUP’s New Monkeypox Test Can Be Performed on More Specimen Types on High-Throughput Instruments

ARUP has launched a new, in-house test to detect the DNA of orthopoxviruses, including monkeypox.

New Executive Appointments Position ARUP Laboratories for Future Growth

Jonathan Genzen, MD, PhD, has been named chief medical officer and Adam Barker, PhD, has been named chief operations officer as part of a realignment of executive responsibilities.